Tissue‐Resident Memory T Cells: Pioneering New Avenues in Cancer Immunotherapy
T<sub>RM</sub> represent a promising target for cancer immunotherapy due to their potent anti-tumor functions and responsiveness to ICB. Understanding their biology and regulatory networks opens new avenues for therapeutic intervention.
Authors
- Zhi‐Jun Sun (ORCID: https://orcid.org/0000-0003-0932-8013)
- Yao Xiao (ORCID: https://orcid.org/0009-0006-5540-8021)
- Qi‐Chao Yang
Institutions
- Wuhan University (CN)
Publication Details
- Journal
- Cancer Medicine
- Published
- 2025-12-01
- DOI
- https://doi.org/10.1002/cam4.71429
- Primary Topic
- CAR-T cell therapy research
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- National Natural Science Foundation of China
- Fundamental Research Funds for the Central Universities